PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PEN - US70975L1070 - Common Stock
315.86 USD
-0.09 (-0.03%)
316 USD
+0.14 (+0.04%)
Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 185 industry peers in the Health Care Equipment & Supplies industry. PEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes PEN very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year PEN was profitable.
PEN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 9.40%, PEN belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
PEN has a better Return On Equity (12.07%) than 88.65% of its industry peers.
PEN has a Return On Invested Capital of 7.37%. This is amongst the best in the industry. PEN outperforms 82.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.82%.
The last Return On Invested Capital (7.37%) for PEN is above the 3 year average (2.98%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROIC | 7.37% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
PEN has a better Profit Margin (12.30%) than 88.11% of its industry peers.
In the last couple of years the Profit Margin of PEN has declined.
With an excellent Operating Margin value of 12.95%, PEN belongs to the best of the industry, outperforming 80.54% of the companies in the same industry.
In the last couple of years the Operating Margin of PEN has declined.
The Gross Margin of PEN (66.80%) is better than 70.27% of its industry peers.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEN is destroying value.
The number of shares outstanding for PEN has been reduced compared to 1 year ago.
The number of shares outstanding for PEN has been increased compared to 5 years ago.
PEN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 21.16 indicates that PEN is not in any danger for bankruptcy at the moment.
PEN has a better Altman-Z score (21.16) than 95.14% of its industry peers.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
PEN has a Debt to FCF ratio of 0.15. This is amongst the best in the industry. PEN outperforms 93.51% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
PEN has a Debt to Equity ratio of 0.02. This is in the better half of the industry: PEN outperforms 71.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 21.16 |
ROIC/WACC0.84
WACC8.78%
2.3 Liquidity
PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a better Current ratio (6.73) than 84.86% of its industry peers.
A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
PEN's Quick ratio of 4.18 is fine compared to the rest of the industry. PEN outperforms 76.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 36.47% over the past year.
PEN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.23% yearly.
Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 14.61% in the last year.
PEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.89% yearly.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
3.2 Future
PEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.42% yearly.
Based on estimates for the next years, PEN will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y32.46%
EPS Next 2Y33.3%
EPS Next 3Y31.11%
EPS Next 5Y24.42%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.5%
Revenue Next 5Y13.24%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 87.01, which means the current valuation is very expensive for PEN.
PEN's Price/Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 65.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of PEN to the average of the S&P500 Index (26.59), we can say PEN is valued expensively.
Based on the Price/Forward Earnings ratio of 61.94, the valuation of PEN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 67.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, PEN is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.01 | ||
| Fwd PE | 61.94 |
4.2 Price Multiples
64.86% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than the industry average as 70.81% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 81.04 | ||
| EV/EBITDA | 61.9 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PEN may justify a higher PE ratio.
A more expensive valuation may be justified as PEN's earnings are expected to grow with 31.11% in the coming years.
PEG (NY)2.68
PEG (5Y)3.59
EPS Next 2Y33.3%
EPS Next 3Y31.11%
5. Dividend
5.1 Amount
No dividends for PEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
315.86
-0.09 (-0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.87%
Inst Owner Change6.18%
Ins Owners3.7%
Ins Owner Change5.5%
Market Cap12.37B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts83.33
Price TargetN/A
Short Float %4.04%
Short Ratio3.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)-0.35%
PT rev (3m)0.15%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-1.9%
EPS NY rev (1m)0.7%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.01 | ||
| Fwd PE | 61.94 | ||
| P/S | 9.27 | ||
| P/FCF | 81.04 | ||
| P/OCF | 60.85 | ||
| P/B | 9.1 | ||
| P/tB | 10.43 | ||
| EV/EBITDA | 61.9 |
EPS(TTM)3.63
EY1.15%
EPS(NY)5.1
Fwd EY1.61%
FCF(TTM)3.9
FCFY1.23%
OCF(TTM)5.19
OCFY1.64%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.68
PEG (5Y)3.59
Graham Number53.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROCE | 10.97% | ||
| ROIC | 7.37% | ||
| ROICexc | 10.5% | ||
| ROICexgc | 12.46% | ||
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% | ||
| FCFM | 11.44% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 291.22% | ||
| Cap/Sales | 3.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.89% | ||
| Profit Quality | 93.05% | ||
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 21.16 |
F-Score7
WACC8.78%
ROIC/WACC0.84
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y32.46%
EPS Next 2Y33.3%
EPS Next 3Y31.11%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.5%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year81.21%
EBIT Next 3Y42.41%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%
PENUMBRA INC / PEN FAQ
What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?
ChartMill assigns a fundamental rating of 6 / 10 to PEN.
Can you provide the valuation status for PENUMBRA INC?
ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.
What is the profitability of PEN stock?
PENUMBRA INC (PEN) has a profitability rating of 6 / 10.
What are the PE and PB ratios of PENUMBRA INC (PEN) stock?
The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 87.01 and the Price/Book (PB) ratio is 9.1.
Can you provide the financial health for PEN stock?
The financial health rating of PENUMBRA INC (PEN) is 8 / 10.